InnerScope Hearing Technologies (OTC: INND) is an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space and over-the-counter (“OTC”) hearing technology market. The company today announced that its CPA firm, Paris, Kreit & Chiu LLP (“PKC LLP”), has completed PCAOB audits of the company’s 2019 and 2020 annual financial statements. The annual reports have been filed with the U.S. Securities & Exchange Commission (“SEC”) on Form 10-K and are available to view at www.sec.gov. “InnerScope is pleased to announce that the company has completed and filed its 2019 and 2020 audited financial statements with the SEC. This has been our major priority for some time now, and audit completion is a critical step to becoming a fully reporting public company with the SEC,” said Matthew Moore, president and CEO of InnerScope. “Becoming a fully reporting company is a critical and required step to ultimately listing our shares on the NASDAQ stock exchange, another important objective for InnerScope, which is currently one step nearer to being realized.”
To view the full press release, visit https://ibn.fm/VPVY7
About InnerScope Hearing Technologies Inc.
InnerScope is a leading direct-to-consumer (“DTC”) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products, and personal sound amplifier products (“PSAPs”) (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s products and its business model break through the persistent barriers that prevent access to effective hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a DTC cloud-based hearing solution provider, gives the company access to over 40 patents and an FDA-registered manufacturing and R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the direct-to-consumer hearing solutions market by selling advanced hearing products through Walmart and other major retailers. InnerScope’s full line of hearing health products is currently available through these multiple retail/wholesale channels: Walmart Vision Centers, Walmart.com, Walmart Canada, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, FSAStore.com, HSAStore.com and WellDeservedHealth.com. More in-store and online hearing products are launching soon with additional major retailers and pharmacy chains. For information related to InnerScope Hearing Technologies’ latest hearing aids and related hearing products, please visit www.iHearDirect.com and www.HearingAssist.comt. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.
NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.